Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy
It’s been a hard week for the psychedelics pioneer Rick Doblin. First, the Food and Drug Administration declined to approve the MDMA-assisted therapy for post-traumatic